MUHAMMAD MURTAZA SHAFQAT, ALI RAZA NAQVI, AMIR SHAFIQUE, RASHID ALI KHOSA, SHABEER AHMED, HAZAR KHAN BUGTI. Ryzodeg (Insulin Degludec/Aspart) for Type 2 Diabetes in Pakistan: A 12-Week Study on Glycemic Control and Safety Outcomes. Pakistan Journal of Medical & Health Sciences, [S. l.], v. 16, n. 09, p. 1003, 2022. DOI: 10.53350/pjmhs221691003. Disponível em: https://pjmhsonline.com/index.php/pjmhs/article/view/6542. Acesso em: 5 dec. 2025.